The presence of a proton-coupled electrogenic high-affinity peptide transporter in the apical membrane of tubular cells has been demonstrated by microperfusion studies and by use of brush border membrane vesicles. The transporter mediates tubular uptake of filtered di-and tripeptides and aminocephalosporin antibiotics. We have used expression cloning in Xenopus laevis oocytes for identification and characterization of the renal high-affinity peptide transporter. Injection of poly(A)+ RNA isolated from rabbit kidney cortex into oocytes resulted in expression of a pH-dependent transport activity for the aminocephalosporin antibiotic cefadroxil. After size fractionation of poly(A)+ RNA the transport activity was identified in the 3.0-to 5.0-kb fractions, which were used for construction of a cDNA library. The library was screened for expression of cefadroxil transport after injection of complementary RNA synthesized in vitro from different pools of clones. A single clone (rPepT2) was isolated that stimulated cefadroxil uptake into oocytes approximately 70-fold at a pH of 6.0. Kinetic analysis of cefadroxil uptake expressed by the transporter's complementary RNA showed a single saturable high-affinity transport system shared by dipeptides, tripeptides, and selected amino-beta-lactam antibiotics. Electrophysiological studies established that the transport activity is electrogenic and affected by membrane potential. Sequencing of the cDNA predicts a protein of 729 amino acids with 12 membrane-spanning domains. Although there is a significant amino acid sequence identity (47%) to the recently cloned peptide transporters from rabbit and human small intestine, the renal transporter shows distinct structural and functional differences. 
One of the functions of kidney tubular cell is the reabsorption of di-and tripeptides filtered or generated by enzymatic hydrolysis of oligopeptides after glomerular filtration. The presence of a high-affinity peptide transporter in the apical membrane of tubular cells was demonstrated by microperfusion studies (1) and in isolated brush border membrane vesicles (BBMV) (2-6). The transporter was found to operate in an electrogenic mode by coupling of substrate influx to an inwardly directed proton gradient. Besides di-and tripeptides, a variety of peptide mimetics with a peptide backbone were found to interact with the transporter's substrate-binding site (7) (8) (9) (10) (11) (12) .
The following observations made it possible to clone a cDNA from rabbit kidney cortex that codes for a protein related to peptide and aminocephalosporin transport: (i) Injection of poly(A)+ RNA isolated from rabbit kidney cortex into Xenopus laevis oocytes resulted in the expression of saturable sodium-independent transport activity for the aminocephalosporin [3H] cefadroxil. ( ii) The mRNA coding for the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. X. laevis Oocytes and Transport Assay. The techniques and methods concerning preparation and handling of oocytes have been described in detail (14, 15) . Oocytes were injected with 50 nl of water (controls) or 50 nl of RNA solutions containing either poly(A)+ RNA or the transporter complementary RNA (cRNA), and 3 days later uptake of [3H] cefadroxil and selected 3H-labeled compounds was measured for 30 min in a buffer composed of 100 mM NaCl (or choline chloride), 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes)/Tris for pH values 2 6.5 or 10 mM 2-(N-morpholino)ethanesulfonic acid (Mes)/ Tris for pH values c 6.5. Uptake rates of cefadroxil into water-injected control oocytes were always subtracted from uptake rates in oocytes expressing rPepT2.
Construction and Screening of cDNA Libraries. Since enhanced transport activity for cefadroxil was identified in the 3.0-to 5.0-kb fractions of the poly(A)+ RNA, an expression library was constructed with the corresponding cDNAs by the Super-Script plasmid system II (pSPORT1 vector; GIBCO/ BRL). The library contained -1.7 X 105 colonies, of which 40,000 have been screened by a sib-selection procedure (15) ; initial pools for screening contained "2000 colonies. Plasmid DNA was isolated by alkaline lysis. Plasmids were linearized with Not I and used for in vitro synthesis of cRNA as described previously (14) . The cRNA was dissolved in water, and 50 nl of water (control) *To whom reprint requests should be addressed. IThe sequence reported in this paper has been deposited in the GenBank data base (accession no. U32507). IlParts of this work were presented at the Experimental Biology Meeting, April 9-13, 1995, Atlanta, and published in abstract form (13).
Electrophysiology. A conventional two-electrode voltage clamp technique was applied to characterize responses in current (I) and transmembrane potential (Vm) to substrate addition in oocytes injected with 5 ng of transporter cRNA as described (16, 17) . Steady-state current-voltage (I-V) relationships were measured in the absence and the presence of 1 mM cefadroxil at pH values of 7.4, 6.5, and 5.5. Membrane potential in oocytes was held at -60 mV and stepped symmetrically to test potentials from -150 mV to +50 mV by 500-ms rectangular voltage pulses, and current recordings were obtained during the last 100 ms.
Isolation of Poly(A)+ RNA and Northern Blot Analysis. Total RNA from rabbit tissues was isolated by the acid guanidinium thiocyanate/phenol/chloroform extraction procedure, and polyadenylylated mRNA was purified from total RNA preparations by using Dynabeads oligo(dT)25 (Dynal, Oslo). Then 3.5 ,ug of poly(A)+ RNA was separated electrophoretically on a formaldehyde-containing 1.5% agarose gel and blotted onto a nylon membrane. The rPepT2 mRNA was hybridized with an antisense RNA probe labeled with digoxigenin-UTP (Boehringer Mannheim). The hybridization probe was generated from a 1. 24 (Eurogene, Seraing, Belgium) to proceed throughout the entire sequence as described previously (15) .
Calculations. All calculations were performed by using INPLOT (GraphPad, San Diego). The experiments were generally carried out in triplicate with at least three batches of oocytes, and results are presented as the mean ± SEM.
RESULTS AND DISCUSSION
A single clone (rPepT2) was isolated by screening for expression of pH gradient-dependent uptake of cefadroxil in X laevis oocytes. Injection of various amounts (0.1-25 ng) of the cRNA synthesized from this clone increased uptake of cefadroxil up to 70-fold over background at 0.1 ,uM cefadroxil (Fig. 1) with 5 ng of the transporter cRNA compared with waterinjected controls (data not shown). When influx of cefadroxil was determined as a function of incubation pH, a distinct pH profile was obtained. Uptake increased severalfold when the pH was decreased from 8.0 to 6.0 or 5.5 (Fig. 2) . In contrast, cefadroxil uptake in water-injected control oocytes was hardly detectable and did not respond significantly to alterations in external pH. The cation specificity of the induced transport activity in cRNA-injected oocytes was determined both at low pH (pH 6.0) and high pH (pH 7.4, not shown) by replacing NaCl with choline chloride. At neither pH did the replacement of Na+ reduce cefadroxil influx (Fig. 2) , indicating that HI rather than Na+ may serve as the cotransported ion species. Cefadroxil influx into oocytes expressing rPepT2 displayed saturation kinetics as a function of substrate concentration at external pH values of 8.0 to 6.0 (Fig. 3 ). In agreement with previous studies in BBMV (1, 8, 10) , the transporter shows a high affinity for cefadroxil (<50 ,tM) at all pH values tested.
Substrate affinity ranged from 24 to 41 ,tM and appeared to be unaffected by external pH, whereas Vmax was strongly dependent on the transmembrane pH gradient imposed (Fig.  3 ). Maximal transport rates could be increased almost 4-fold by reducing pH from 8.0 to 6.0. Similarly, a low external pH has been shown to increase the Vmax of uptake of dipeptides and 13-lactam antibiotics into kidney BBMV without affecting substrate affinity (6, 10).
To further characterize the induced transport activity with respect to the driving force, we determined the voltage-and pH gradient-dependence of cefadroxil uptake. Membrane potential was measured by conventional two-electrode voltage clamp techniques as described (16, 17) . When oocytes expressing rPepT2 were preincubated with low-Na+ (1 mM)/high-K+ (102 mM) buffers at pH 6.0, steady-state membrane potential was reduced from -45 ± 3 mV (control: 100 mM Na+/3 mM 0. 8 07 07 oo 0.6 oL 1. Experiments were performed at pH 7.4, 6.5, and 5.5 in the absence or the presence of 1 mM cefadroxil (0) or the dipeptide Gly-Asp (0). The transport rate is expressed as percent increase in current at pH 6.5 and 5.5 compared to the absence of a pH gradient (pH 7.4). Data are presented as means + SEM for repeated measurements in 5-8 oocytes per condition. The data were submitted to linear regression analysis, and the P value of -s0.005 indicates a significant dependence of transport activity on external pH.
cefadroxil mediated by rPepT2 is significantly (P e 0.001) affected by the membrane potential. When the substrateinduced currents at different pH values (holding potential, -60 mV) were plotted against the medium pH a linear relationship was obtained (Fig. 5 ). As in [3H]cefadroxil influx into oocytes (Fig. 3) , the transport rate increased 3-fold when the external pH was decreased from 7.4 to 5.5. Since the net charge of the substrate does not change significantly in the pH range applied (18) , the relationship clearly indicates that the substrate-induced proton influx generates the currents obtained. From the studies described above we conclude that the expressed transport activity resembles an electrogenic substrate/H+ cotransport system that is significantly affected by membrane potential.
Since studies in kidney BBMV established that the transporter has a broad substrate specificity (7-9), we determined the selectivity of interaction of peptides, ,B-lactam antibiotics, and aminopeptidase inhibitors with the substrate-binding site by inhibition studies. pH gradient-dependent cefadroxil uptake (25 ,uM) was measured in the absence or the presence of 5 mM inhibitor. As shown in buffer (100 mM NaCl) and membrane potential was held at -60 mV.
Thereafter membrane potential was stepped symmetrically to the test potential shown and substrate-dependent currents were obtained as the difference measured in the absence and the presence of 1 mM cefadroxil and Gly-Asp. Data are presented as means ± SEM for 5-9 individual oocytes per condition. alanyl peptides we observed that only di-and tripeptides but not peptides with more than three amino acid residues interact with the substrate-binding site of the transporter. The stereospecificity of interaction was determined by peptides containing either L or D isomers of alanine in different positions (Fig. 6A) . Incorporation of D-alanine into the N-terminal position maintained an inhibitory potency of the peptide, whereas peptides with D-alanine in the C-terminal position or in both positions failed to inhibit cefadroxil uptake. Of the various ,3-lactam antibiotics tested, only the cephalosporins carrying a free a-amino group (loracarbef, cefaclor, and cephalexin) reduced cefadroxil influx (Fig. 6B) . This is consistent with previous observations in kidney BBMV (7, 8, 10) . From a variety of other compounds suggested to serve as substrates for the peptide transporters in epithelial cells, we chose to investigate whether angiotensin-converting enzyme (ACE) inhibitors and aminopeptidase inhibitors such as arphamenin A and bestatin inhibited cefadroxil transport mediated by rPepT2. Whereas 5 mM bestatin or arphamenin A significantly reduced cefadroxil uptake by 55% 4% and 62% + 7% (data not shown), no inhibition was seen with any of the ACE inhibitors tested (captopril and enalapril) (Fig. 6B) .
In summary, it appears that only di-and tripeptides, aminocephalosporins, and selected aminopeptidase inhibitors interact with the substrate-binding site of the transporter. In contrast to the intestinal peptide/H+ symporter PepTi (17), ACE inhibitors and 3-lactam antibiotics without an a-amino group appear not to be transported by the renal carrier protein.
On the basis of functional criteria, including the driving force, kinetics of transport, and substrate specificity and affinity, rPepT2 shows some similarities with PepTI but also distinctly different features, including a different pH dependence (under identical experimental conditions, including the substrate), a 40 times higher substrate affinity, and a different substrate specificity. The observed differences in structure and function of the intestinal peptide transporter PepTI and the renal clone rPepT2 are summarized in Table 1 .
Tissue-specific expression of the mRNA corresponding to rPepT2 was examined by Northern blot analysis (Fig. 7) . In the rabbit, a mRNA species of 4.8 kb from kidney cortex hybridized with the 1.24-kb RNA probe. Signals of similar or identical size were obtained also in rabbit brain, lung, liver, and heart at both low and high stringencies (Fig. 7) . Although peptide transporters with functions like those of rPepT2 have not been described yet in any other tissue but kidney and intestine, Northern analysis suggests that similar transporters may be expressed in other tissues, where they could contribute to the removal of short-chain peptides and peptide-derived drugs circulating in the blood.
The cDNA insert of our clone was completely sequenced on both strands. It is 4265 bp long, and the deduced amino acid sequence (Fig. 8) from the open reading frame of the nucleotide sequence indicated that the gene product is a protein of 729 amino acids. Hydropathy analysis, performed as described previously (14, 15) , predicted 12 membrane-spanning domains with a large extracellular loop between transmembrane domains 9 and 10. Besides five putative extracellular Nglycosylation sites, four intracellular consensus regions containing protein kinase C motifs have been identified. In comparisons with other members of the POT family of protondependent oligopeptide transporters (18) or the major facilitator superfamily (19) by using the BLAST program, the predicted rPepT2 amino acid sequence shows a high identity (47%) and similarity (67%) only with the intestinal peptide transporter PepTl recently cloned from the rabbit small intestine (17, 20) . However, the significant identity is predominantly found in the membrane-spanning domains, whereas the large extracellular loop, which contains 210 amino acid residues, shows only a 21% sequence match. Comparisons with nonmammalian POT family members like the nitrate transporter CHL1 from Arabidopsis thaliana (21) and the peptide permease PTR2 from Saccharomyces cerevisiae (22) reveal much lower sequence similarities.
In vitro translation of rPepT2 cRNA using a rabbit reticulocyte lysate in the absence and the presence of canine pancreatic microsomes yielded translation products with apparent molecular mass of 83 and 107 kDa, respectively (Fig. 7) . The multiple N-glycosylation sites with core glycosylation therefore appear to account for almost 24 kDa of the overall molecular mass of the rPepT2 gene product. We recently reported the photolabeling of a 105-kDa protein in BBMV of rat kidney cortex by using [3H]cefadroxil as a photoprobe (23) . Incorporation of the photolabel into the 105-kDa membrane protein was inhibited by (i) competing substrates, (ii) a collapse of the protonmotive force, and (iii) 
attcca ccaacaaa4tttccatt catggcaactgccacagtat cctg taaca ct 1873 Note Added in Proof. During the reviewing of this manuscript, a report describing the cloning of a peptide transporter from human kidney was published (24) . PepT2 from human kidney has significant homology to rPepT2 described in the present paper.
